Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists-Reference-Cited by-同舟云学术

Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists

Published:2017-05-05 Issue:10 Volume:60 Page:4293-4303
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Evers Andreas¹^ORCID,Haack Torsten¹,Lorenz Martin¹,Bossart Martin¹,Elvert Ralf¹,Henkel Bernd¹,Stengelin Siegfried¹,Kurz Michael¹,Glien Maike¹,Dudda Angela¹,Lorenz Katrin¹,Kadereit Dieter¹,Wagner Michael¹

Affiliation:

1. R&D, Sanofi-Aventis Deutschland GmbH, Industriepark Höchst Building G838, D-65926 Frankfurt am Main, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b00174

Reference49 articles.

1. Diabesity: an overview of a rising epidemic

2. Impact of weight gain on outcomes in type 2 diabetes

3. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

4. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

5. Effect of Glucagon on Food Intake and Body Weight in Man

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transforming obesity: The advancement of multi-receptor drugs;Cell;2024-07

2. Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency;Nature Chemistry;2024-05-16

3. Coordinated ASBT and EGFR Mechanisms for Optimized Liraglutide Nanoformulation Absorption in the GI Tract;International Journal of Nanomedicine;2024-03

4. Design of a novel long-acting dual GLP-1/GIP receptor agonist;Bioorganic & Medicinal Chemistry;2024-02

5. Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists;Journal of Medicinal Chemistry;2023-12-20